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Slln'lmary 
In addition to T cell differentiation in the thymus, we have recently reported that extrathymic 
T cell differentiation occurs preferentially in the sinusoids of the liver. Although this extrathymic 
pathway is relatively minor in normal mice, it becomes predominant in mice with autoimmune 
diseases, athymic mice, and aged mice. In the present study, injection of normal male C3H/He 
mice, 6-8 wk of age, with 1 mg of estrogen resulted in an increase in mononuclear cells (MNC) 
yielded from the liver and a drastic decrease in thymocytes approximately 10 d after such injection. 
This unique modulation was not observed with hydrocortisone injection (5 rag/mouse, i.p.) 
nor with irradiation (5 Gy/mouse). Rather,  these immunosuppressive treatments induced a 
simultaneous decrease in cell number in both the liver and thymus. A time-kinetics study on 
the cell number and spontaneous cell proliferation revealed that an increase in spontaneous cell 
proliferation in the liver preceded the increase in the number of liver MNC, and a decrease in 
spontaneous cell proliferation in the thymus preceded the decrease in the number of thymocytes. 
At this time, an enrichment ofc~/3 T cells with intermediate T cell receptors (TCRs), including 
forbidden T cell oligoclones and V38 + cells, which are characterized as extrathymic o#3 T cells 
with unique properties, took place in the liver. On the other hand, the thymic atrophy induced 
by estrogen resulted in a prominent decrease in immature double-positive (CD4+8 +) 0#3 T 
cells with dull TCRs. These results indicate that estrogen administration activates an extrathymic 
pathway of T cell differentiation in the liver and reciprocally inactivates the intrathymic pathway. 
As extrathymic T  cells have unique characteristics  such as autoreactivity, the present findings 
might be intimately related  to a female predominance of autoimmune diseases and suggest a 
possible  role of estrogen in this phenomenon. 
M 
any clinicians and investigators have observed that the 
female has a greater propensity for the occurrence of 
various autoimmune diseases than the male. Actual diseases 
and female-to-male ratios showing a female predominance 
of autoimmune diseases were reviewed in both humans and 
animals (1). Although the mechanisms underlying this sex 
difference are imperfectly understood, it has been suspected 
that sex hormones might be directly or indirectly associated 
with this phenomenon. In this respect, estrogen has often 
been suggested as one of the most probable candidates. For 
example, abnormal estrogen metabolism resulting in prolonged 
estrogenic stimulation induced or deteriorated diseased states 
in SLE patients (2) and administration of oral contraceptives 
(containing estrogen) to SLE patients exacerbated the disease 
(3, 4). In experimental animals, estrogen administration was 
also reported to accelerate autoimmune  diseases (5, 6). In par- 
allel with these observations, intensive studies on the immuno- 
logical effects of estrogen have been reported (7-10).  It was, 
however, noticed that the effects of estrogen on the immune 
system so far described did not sufficiently elucidate possible 
mechanisms of sex hormones involved in the occurrence of 
autoimmune diseases. It was therein reported that estrogen 
administration induced profound thymic atrophy and resulted 
in  immunosuppressive effects  on  the peripheral  immune 
systems. It seems that many difficulties face attempts to clarify 
the relation between the mechanisms involved in immuno- 
suppression  and  autoimmune states.  Moreover,  estrogen 
administration has been found to sometimes inhibit certain 
autoimmune diseases, i.e.,  experimental autoimmune en- 
cephalomyelitis (11) and experimental autoimmune thyroid- 
iris (12, 13). It is, therefore, expected that more appropriate 
or different approaches should be applied to resolve confu- 
sion in this area. 
It is widely known that T cells differentiate in the thymus 
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tion to form the repertoires of mature T  cells (14-17).  In 
addition to this intrathymic pathway of T  cell differentia- 
tion, we have recently demonstrated that both ot/~ and 3'//i 
T cells may differentiate extrathymically in the liver of humans 
and mice (18,  19). Although the hepatic pathway of T  cell 
differentiation is relatively minor in normal mice, this pathway 
becomes predominant in mice subjected to bacterial stimula- 
tion (20),  in mice with malignancies (21), in autoimmune 
MILblpr/Ipr mice (18), in congenitally athymic nude mice, 
and in aged mice with involuted thymus (22).  ot/B T  ceils 
that differentiate in the liver have several unique properties: 
(a) even forbidden T cell oligoclones could be generated after 
bacterial stimulation probably due to the lack of the double- 
positive (DP) 1 CD4+8 + stage for negative selection (20); (b) 
V/~8 + cells,  which are known to be intimately related to 
various autoimmune disease mice, were preferentially gener- 
ated (23);  and (c) the majority of extrathymic ot/B T  cells 
residing in the liver had an intermediate intensity of TCRs 
(23). It is conceivable that extrathymic c~/~/T cells may be 
important in the surveillance of bacterially infected cells and 
atypical cells generated in vivo, and that an overstimulation 
of such T cells (by undetermined causes) may be responsible 
for the onset of autoimmune diseases. 
The object of the present study was to investigate how 
estrogen administration affects extrathymic T cell differenti- 
ation in the liver. It was demonstrated that estrogen adminis- 
tration might profoundly activate the extrathymic process of 
T cell differentiation in the liver and, instead, suppress  the 
intrathymic process in the thymus. The possible dose rela- 
tion of the present findings to the mechanisms involved in 
the female preponderance of autoimmune diseases is discussed. 
Materials  and Methods 
Mice.  Male  C3H/He mice (H-2  k, Mls-2a), aged 6-8 wk, were 
obtained from Charles R.iver  Japan Inc. (Tokyo,  Japan). They were 
fed under specific pathogen-free conditions (19, 20). 
Estrogen Administration.  I mg of estrogen (Ovahormone depo; 
Teikoku Zoki, Inc., Japan)/mouse was subcutaneously injected. As 
estrogen is dissolved  in sesame  oil (i.e., due to being water insoluble), 
only the subcutaneous injection, but not the intravenous or in- 
traperitoneal routes, is available. To investigate the unique effects 
of estrogen, mice injected intraperitoneally with hydrocortisone 
(5 rag/mouse; Sigma Chemical Co., St. Louis, MO) and mice ir- 
radiated with 5 Gy were also used. 
Cell Preparation.  Treated and untreated mice were killed, and 
mononuclear ceils (MNC) were prepared from the liver, thymus, 
and spleen. Liver MNC were obtained as previously described (19, 
20). Briefly, to eliminate blood from the liver before its removal, 
it was perfused with 10 ml PBS (0.01 M, pH 7.2) via the portal 
vein. To obtain MNC, the liver was pressed through 100-gauge 
stainless steel mesh and suspended in RPMI 1640 supplemented 
with 5% FCS. After one washing with the medium, the cells were 
resuspended in 20 ml of the medium and MNC were isolated from 
1  Abbreviations  used in this  paper:  DN, double  negative;  DP, double  positive; 
MNC, mononudear cells. 
parenchymal hepatocytes by Ficoll-Isopaque density (1.090) gra- 
dient centrifugation. In the MNC preparation method applied here, 
the proportion of contaminated Kupffer cells  was negligible (<4%). 
The cell yield was '~10-15%  (18). MNC of the spleen were also 
collected by the Ficoll-Isopaque  method, whereas thymocytes were 
obtained by forcing the thymus through 100-gauge mesh (19, 20). 
CellProliferation  Assay.  The activity of spontaneous cell prolifer- 
ation  was analyzed by [3H]thymidine uptake  into DNA  (19). 
Briefly, freshly isolated MNC (5  x  l0  s cells/0.2 ml medium) were 
cultured in a 96-well round-bottomed microplate (Falcon Labware, 
Oxnard, CA) for 18 h at 37"C in a CO2 incubator. 0.5 gCi of 
I3H]thymidine (Amersham International,  Amersham, England) 
was added at the initiation of culture. The medium used here was 
RPMI 1640 supplemented with 1% fresh mouse serum and 5  x 
10 -s M 2-ME. The data express the mean cpm _+ 1 SD of tripli- 
cate cultures. 
Immunofluorescence  Test.  Surface  phenotypes ofceUs were iden- 
tified by using mAbs in conjunction with the single- or two-color 
immunofluorescence test (18-20). The mAbs used here included 
biotin-conjugated hamster anti-~/B-TCR (H57-597) (24), FITC- 
conjugated mouse anti-V~8 (F23.1) (25), FITC-conjugated ham- 
ster anti-CD3 (145-2Cll), unconjugated hamster anti-VO3 (KJ25- 
606-4) (26), and biotin-conjugated Ib2R/~ chain (TM-/~I) (kindly 
provided from Drs. T. Tanaka and M. Miyasaka, The Tokyo Met- 
ropolitan Institute of Medical Science, Tokyo, Japan) mAbs (27). 
Biotin-conjugated  reagent was developed  with PE-conjugated  avidin, 
and unconjugated reagent was developed  with PE-conjugated goat 
anti-hamster Ig (Caltag Laboratories, San Francisco, CA). FITC- 
conjugated rat anti-CD4  (L3T4) and PE-conjugated anti-CD8 
(Lyt2) mAbs were also used (Becton Dickinson & Co., Mountain 
View, CA).  The fluorescence-positive cells were analyzed by a 
FACScan  |  (Becton Dickinson & Co.). 
Results 
Unique Effects of  Estrogen on the Number of  MNC in the Liver 
and Thymus.  When C3H/He mice were subcutaneously in- 
jected with estrogen (1 rag/mouse), a prominent increase of 
the number of MNC obtained from the liver was demon- 
strated 10 d  after the injection (Fig.  1). In contrast, severe 
thymic atrophy and resulting decrease in the number of thymo- 
cytes occurred at the same time. To emphasize this unique 
effect of estrogen, we also examined the number of MNC 
in the liver and thymus of mice injected with hydrocortisone 
(5 rag/mouse) or of mice irradiated with 5 Gy, which are 
known to be representative immunosuppressive treatments. 
After 5 d of these treatments, simultaneous decreases in the 
number of MNC in the liver and thymus occurred. The sup- 
pressive effect of hydrocortisone (5 mg/ml) was induced by 
both intraperitoneal and subcutaneous routes of injection (our 
unpublished observation).  The maximum suppression was 
also achieved by both routes 5 d  after the injection. 
Time-Kinetics of Variations in the Number of  MNC in the Liveg, 
Thymus, and Spleen after Estrogen Administration.  Precise time- 
kinetics of variations in the number of MNC was then ana- 
lyzed (Fig. 2). After 5 d of estrogen administration, the number 
of MNC in the liver began to increase, reached a peak on 
day 13, and then decreased gradually. The variation in the 
number of thymocytes appeared to be completely reversed, 
since the number of thymocytes began to decrease 3 d after 
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Figure t.  Variation  of the number of MNC in the liver and thymus 
of mice treated with estrogen, hydrocortisone, and irradiation. Four mice 
were subcutaneously  injected with estrogen (1 rag/mouse) and killed 10 d 
after the injection, whereas  four mice were intraperitoneally injected with 
hydrocortisone (5 rag/mouse) and killed 5 d after the injection. Four ir- 
radiated mice (5 Gy/mouse)  were also used 5 d after the treatment. Data 
~press mean _+  1 SD. 
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Figure 3.  Time-kinetics  of variation in the spontaneous proliferation 
of liver MNC and thymocytes after estrogen administration. Each plot 
was based on the data of four individual mice treated. 
the injection, reached a base line on day 7, and then showed 
a gradual restoration  15 d  after the injection.  A  pattern of 
variation similar to that seen in the thymus was also observed 
in the spleen, although  the variation was not so drastic as 
that  in the thymus. 
Reciprocal Change between the Liver and Thymus  Was also 
Observed in Spontaneous Cell Proliferation.  in contrast to lym- 
phocytes obtained from the peripheral  immune organs, spleen, 
and lymph  nodes,  thymocytes and  freshly isolated hepatic 
MNC often showed increased spontaneous cell proliferation 
in in vitro culture (18,  21). This spontaneous cell prolifera- 
tion was serially analyzed in the liver and thymus after es- 
trogen administration  (Fig. 3). Interestingly,  an increase in 
spontaneous proliferation of the hepatic MNC was observed 
to coincide with the period when the number of MNC in- 
creased.  On the other hand,  the spontaneous proliferation 
of thymocytes disappeared coincident with the time when 
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Figure 2.  Time-kinetics  of variations in MNC number of the liver, 
thymus, and spleen after estrogen administration. Each plot was based 
on the data of four individual mice tested. 
the  number  of thymocytes was  at  the  base line.  Strictly 
speaking, an increase in the spontaneous cell proliferation in 
the liver seemed to slightly precede the increase in the number 
of MNC, whereas a decrease in the spontaneous cell prolifer- 
ation in the thymus seemed to precede the decrease in the 
number  of thymocytes. 
Specific Activation of et/# T Cells with Intermediate TCR in 
the Liver.  It was previously reported that MNC in the liver 
contained a large population of ol/B T  ceUs with either in- 
termediate TCK or bright TCK (20, 23). The staining pat- 
tern of TCK, V/38,  CD3,  and V~3 antigens was analyzed 
in the liver MNC before and after the injection (Fig.  4). It 
was confirmed that or//3 T cells in the liver consisted of both 
intermediate TCR (or CD3) and bright TCK (or CD3). The 
former cells were a relatively minor population in the liver 
as compared with the latter cells in untreated control mice. 
10 d after injection, almost all T cells were composed of in- 
termediate TCK. This pattern was quite similar to that seen 
in the liver of autoimmune MRL-Ipr/Ipr mice and thymec- 
tomized mice as we previously reported  (23). 
In a recent study, we developed the most accurate method 
to  identify  intermediate  TCK  ceils  by  a  two-color  im- 
munofluorescence test using anti-CD3 and anti-Ib2RB mAbs 
(H. Watanabe, manuscript in preparation).  By applying this 
method,  we investigated the kinetics of estrogen dose and 
the time course in hepatic MNC (Fig. 5). The results on days 
5 and 10 are represented and the doses used here were 0.125, 
0.25, 0.5, and 1 mg/mouse of estrogen. We noticed that the 
time course after estrogen administration showed the delayed 
onset (approximately several days after the injection) and long- 
lasting effect, especially at the high doses, were probably due 
to the effect of the oil solvent or the intrinsic  property of 
estrogen. As intermediate TCK cells (encompassed by squares 
in Fig. 5), as well as CD3-  NK cells,  expressed primarily 
the high level of ID2P,~, the peak of intermediate TCR cells 
(18.2%) was clearly demonstrated  even in untreated  mice. 
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Figure 4.  Specific  activation  of ot/B T  cells with intermediate  TCRs in the liver, A representative  result  of four isolated experiments  is shown. 
This proportion was increased as a function of estrogen dose 
up to >50%.  The low doses of estrogen (0.125 and 0.25 
mg/mouse) showed a relatively small effect on day 10. After 
an application of this accurate method, we know that the 
actual proportion of intermediate ~/~-TCR. cells in the liver 
is lower than those identified by the single-color method. 
An Increase of VflS+/w_/'I?-TCR + Ratios and Generation of 
Forbidden T Cell Oligoclones after Estrogen Administration.  We 
then investigated whether the increase of cl/[3 T cells with 
intermediate TCR in the liver after estrogen administration 
was accompanied by the generation of Vfl8 + cells and for- 
bidden T cell clones (Table 1). It was demonstrated that oe/J 
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Figure 5.  FACS  profiles of a two-color immunofluorescence test: the identification of intermediate TCR cells and the proportional increase by estrogen 
administration  as a function of dose. Here,  intermediate  TCR cells (encompassed by squares) were identified by the two-color immunofluorescence 
test  using anti-CD3 and anti-IL-2R43 mAbs. 
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Estrogen Administration 
Percent fluorescence- 
positive cells 
Intensity of 
Cell marker  TCR  -  Estrogen 
=/~ TCR 
~  1/~0| ,.,~ 
.............  I  ....... 
c~/3-TCR +  Intermediate  15.3 _+  2.3  63.1 -+  5.2 
Bright  46.4  _+  3.4  15.5 _+ 0.3  / 
V38 §  Intermediate  8.1_+  0.3  50.3_+ 4.7  ~  1  / 
Bright  12.8  +  0.4  5.0  +  0.1  ~  ]  ~ 
I 
F- 
CD3 §  Intermediate  18.8 -+ 0.4  79.8 -+  5.8  nn 
Bright  52.8  -+ 4.8  6.3  _+ 0.1 
10 ~  10'  10 =  lO ~'  10 4  VB8+/odB-TCR +  Intermediate  52.9 _+  3.4  79.7 _+  4.6 
Green  fluorescence 
Bright  27.6  _+  2.8  32.3 +  2.9 
Five mice were individually  examined, and the mean and 1 SD are 
represented. 
T cells with intermediate TCR (or CD3) became predomi- 
nant after estrogen administration and that such intermediate 
TCR cells contained abundant VB8 + cells (79.8  _+  5.8%; 
n  =  5). Even before estrogen administration, intermediate 
TCR cells in the liver contained a considerably high propor- 
tion of VB8 + cells (52.9  _.  3.4%),  whereas bright TCR 
cells showed a constantly low level ('~30%) of V38 + cells 
irrespective  of estrogen administration. 
The  proportion  of V33 +  cells,  which  are  reactive  to 
Mls-2 ~ and are therefore one of the forbidden T  cell oligo 
clones for C3H/He (Mls-2  ~) mice, was also analyzed in the 
liver before and after estrogen administration (see Fig. 4, right, 
and Table  2).  As  expected,  V~3 +  cells were  a  negligible 
proportion (<1%)  in all immune organs tested before es- 
trogen  administration.  On  the  other  hand,  a  significant 
proportion of V33 + cells (8.9  -  1.2%;  n  =  4)  appeared 
only in the liver after injection, ol/3 T cells with intermediate 
Table  2.  Generation of V~3 + Forbidden T  Cell Clone 
in the Liver after Estrogen Injection 
Percent V33 + forbidden T 
cell clone 
Organ  -  Estrogen 
Liver  0.5  _+ 0.1  8.9  +  1.2 
Thymus  0.1  _+  0  0.9  +  0.2 
Spleen  0.9  _+  0.2  2.2  +  0.4 
Lymph nodes  0.4  _+  0.1  0  +  0 
Four mice were individually  examined, and the mean and 1 SD are 
represented. 
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Figure 6.  Decrease  of dull TCR cells in the thymus  after  estrogen ad- 
ministration.  A representative  result of four  isolated  experiments  is shown. 
TCR also appeared  only in the liver, and V33 + cells were 
shown to reside  in this fraction. 
Disappearance of DP ~z/ff T  Cells with  Dull  TCR  in the 
Thymus after Estrogen Administration.  It is well established 
that cx/B T  cells in the thymus consist of both dull TCR 
cells and bright TCR cells (14-17). The former cells are mainly 
immature DP CD4 +  8 + cells before a negative or positive 
selection process, and the latter cells are mature single-positive 
CD4 + or CD8 + cells after the selection process. As thymic 
atrophy and the resulting thymocytopenia were the most 
prominent findings in mice injected with estrogen, we finally 
investigated what type of cells specifically decreased at this 
time (Fig.  6).  A drastic decrease in the proportion of dull 
TCR cells was demonstrated by the staining of both od 
B-TCR and CD3. Although the relative proportion of  bright 
TCR cells in the thymus increased after estrogen treatment, 
calculation showed the absolute number of such bright TCR 
cells was also  shown to decrease (up to  1:5). 
A two-color immunofluorescence test of CD4 and CD8 
staining in the thymus was then analyzed (Fig. 7). As antici- 
pated,  DP  CD4+8 +  cells  selectively  decreased  (80.5  to 
35.0%) after a single injection of estrogen. This fraction cor- 
responded to dull TCR cells in the former experiment. If 
estrogen administration was repeated more than twice every 
other day, the proportion of DP CD4 +  8 + ceils decreased to 
the basal level (<1%)  (data not shown). 
Discussion 
In the present study, we demonstrated that estrogen ad- 
ministration stimulated extrathymic T cell differentiation in 
the liver of mice in terms of the increased  MNC number 
in the liver and an induced predominance of cx/fl T cells with 
intermediate TCRs.  These  tx//5  T  cells  contained V33 + 
(reactive  to Mls-2 ~) forbidden T  cell oligoclones for these 
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Figure  7.  Two-color  immunofluores- 
cence test of CD4 and CD8 staining in the 
thymus. A representative result of  four iso- 
lated experiments is shown.  Numbers in 
the figure express the percentages of fluo- 
rescence-positive cells in the squares. 
mice, and V/~8 + T cells, both of which were, although not 
entirely, previously characterized as extrathymic T cells with 
unique properties seen in the liver of mice under autoim- 
mune conditions (18, 23) and malignancies (19, 21). On the 
other hand, estrogen administration appeared to suppress in- 
trathymic T  cell differentiation in terms of the decreased 
thymocyte number and the disappearance of immature DP 
CD4+8 + cr  T cells with dull TCRs. As an overactivation 
of the extrathymic pathway of T  cell differentiation might 
be responsible for a possible induction or acceleration of au- 
toimmune diseases, the present findings might elucidate the 
immunological basis of the mechanisms involved in the fe- 
male predominance of autoimmune diseases. 
Several investigators  have proposed the existence of an ex- 
trathymic pathway for T cell differentiation in experiments 
utilizing congenitally athymic nude mice (28-30) and in vitro 
culture systems (31, 32).  However,  a consensus has not yet 
been reached, since there is no definite information as to where 
such T  cells differentiate  outside the thymus. We have re- 
cently reported that such ot/~ (and 3'//~) T cells differentiate 
preferentially  in the sinusoids of the liver, especially under 
conditions of autoimmune  diseases (18, 23), malignancies (19, 
21), bacterial  stimulations (20),  and aging (22).  The ex- 
trathymic o~/~ T cells generated in the liver have several  unique 
properties not seen in those differentiated in the thymus. In 
the liver as well as in the thymus, o~/~ T cells show a two- 
peak pattern of dull and bright TCR expression (including 
CD3 antigens) in terms of immunofluorescence  staining in- 
tensity (20). A single-peak pattern of only bright o#~-TCR 
and CD3 is seen in other peripheral immune organs, including 
the spleen, lymph nodes, peripheral blood, intestine, and skin. 
However, the peak of hepatic dull TCR should be estimated 
as "intermediate" because it is somewhat brighter than thymic 
dull TCR (23). As thymectomized  mice (after 2 mo of thymec- 
tomy) had only o~//3 T  cells with intermediate TCR in the 
liver, we have postulated that such o~/~ T cells are a major 
population of extrathymic ol/B T cells. Indeed, congenitally 
athymic mice have o~/~ T cells with intermediate TCR in 
not only the liver but also in the peripheral immune organs, 
spleen,  and lymph nodes (33). 
ot//~ T cells with intermediate TCR seen in the liver are 
comprised of either double-negative (DN) CD4- 8- cells or 
single-positive  (CD4 + or CD8 *) cells, and absolutely lack 
DP CD4+8 + cells (18, 20, 23).  It is therefore,  conceivable 
that extrathymic c~/B T cells lack a process of negative selec- 
tion and that forbidden T cell clones are therefore generated 
in the liver. In addition, only hepatic c~/B  T cells with inter- 
mediate  TCRs  comprise  a  high  proportion  (>60%)  of 
V/~8 +  cell  oligoclones (normal  values  are  "~30%)  (23). 
VB8 + cells have recently been well characterized as the cells 
responsible for the onset of autoimmune disease due to their 
autoreactivity (34). Their roles in the onset of diseases in au- 
toimmune mice, e.g., MRDlpr/Ipr mice (23), mice with ex- 
perimental autoimmune encephalomyelitis (35, 36), and dia- 
betic NOD  mice (37),  have been reported. 
Concerning the above evidence from our recent studies, 
we prefer to consider that estrogen administration activates 
an extrathymic pathway of T cell differentiation in the liver. 
Our subsequent study further demonstrated that repeated in- 
jections of lower doses of estrogen could induce continuous 
activation of the hepatic pathway of T cell differentiation (un- 
published observation).  It is conceivable that such activated, 
extrathymic c~//~ T cells, which contain a large population 
of VB8 + cells and considerable proportions of forbidden T 
cell oligoclones, may be responsible for the induction or ac- 
celeration  of certain  autoimmune diseases. 
We  recently examined the  estrogen  effects on  the ex- 
trathymic T cell differentiation in the liver of athymic nude 
BALB/c-nu/nu mice aged 8 and 20 wk (data not shown). 
In contrast  to  our  expectation, we could not  produce a 
significant  augmentation of extrathymic T  cell differentia- 
tion by estrogen (1 mg/mouse, s.c.) in terms of changes in 
the number of hepatic MHC and the proportion of inter- 
mediate TCR cells. Although we will report that athymic 
nude mice have only intermediate TCR cells in the liver and, 
to some extent, in the periphery, the absolute number of such 
666  Estrogen  Activates Extrathymic  T  Cell Differentiation  in the Liver cells is not high (33).  It is probably that nude mice may not 
have the best microenvironments even for the extrathymic 
T  cell differentiation in the liver. 
We also confirmed a drastic decrease of thymocyte number 
after estrogen administration. Many earlier studies on the im- 
munological effects of estrogen demonstrated a rapid induc- 
tion of thymic atrophy and the subsequent decrease of T lym- 
phocytes in the peripheral immune organs (8, 38-40). In the 
present study, we clearly showed that such a rapid decrease 
in the number of thymocytes was mainly caused by the selec- 
tive disappearance of immature DP CD4+8 + c~/~ T  cells 
with dull TCR. We have further demonstrated that the dis- 
appearance of each DP ot/~ T cell was due to an acceleration 
of the apoptosis normally seen in the thymus (our unpub- 
lished observation). It is noteworthy that activation of ex- 
trathymic T cell differentiation in the liver is always accom- 
panied by an inactivation of intrathymic T cell differentiation, 
i.e., aging (22), malignancies (21), bacterial stimulations (20), 
and estrogen administration.  It is conceivable that the ex- 
trathymic and intrathymic pathways for T  cell differentia- 
tion may be reciprocally regulated by undetermined factors. 
The mechanisms underlying this phenomenon are under in- 
vestigation. We have recently noticed that estrogen adminis- 
tration may activate stromal cells in the thymus (i.e., thymic 
epithelial cells) and possibly stromal cells in the liver (i.e., 
sinusoidal endothelial cells and Kupffer cells),  probably via 
their estrogen receptors on the cell surface (41,  42). 
There were reports that estrogen administration inhibited 
the onset of certain autoimmune diseases  (11-13),  i.e.,  ex- 
perimental autoimmune encephalomyelitis and thyroiditis. In 
contrast to the spontaneous onset of many autoimmune dis- 
eases, those experimental diseases were caused by the injec- 
tion of foreign antigens (even if they mimic autoantigens). 
It is conceivable that at least during the period of onset, such 
experimental diseases might be important for o~/B T  ceUs 
generated intrathymically. If this is the case, estrogen adminis- 
tration is expected to act as an inhibitory factor due to its 
suppressive effect on the intrathymic pathway ofT cell differen- 
tiation.  Our  present  findings  may  explain  some  of the 
conflicting effects of estrogen administration on autoimmune 
diseases. 
A question is raised as to how estrogen administration is 
related to autoantibody production seen in autoimmune dis- 
eases. One possibility is that extrathymic DN CD4-8-  (or 
single-positive) cffB T  ceils with intermediate TCRs have 
a helper function of certain B calls  (e.g.,  CD5 §  B cells). 
Certain DN c~/15 T  ceils have already been reported to be 
associated  with the enhancement of autoantibody produc- 
tion by B ceils (43,  44).  In the autoimmune mice used in 
such studies, extrathymic o~/~ T cells with intermediate TCRs 
may be in activated states in the liver. The interaction of such 
extrathymic o~//3 T  calls with certain B cells remains to be 
further investigated. At least, estrogen administration is known 
to augment antibody production of thymus-independent an- 
tigens (1, 45). Extrathymic T cells may be a candidate in this 
case. In any case, the present results have led us to consider 
the possibility that physiological and pharmacological doses 
of estrogen might activate an extrathymic pathway for T cell 
differentiation.  Such  extrathymic o~/B T  cells  might  be 
beneficial for the surveillance of atypical cells generated in 
vivo due to their autoreactivity. However, if an overstimula- 
tion of this pathway occurs in individuals with certain genetic 
or other traits, they may fall victim to autoimmune diseases. 
In such cases, it is probable that estrogen may act as one of 
the  factors  in  the  female preponderance  of autoimmune 
diseases. 
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